PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 25410673

  • 1. Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.
    Huang YJ, Yang XQ, Zhai WS, Ren XQ, Guo QY, Zhang X, Yang M, Yamamoto T, Sun Y, Ding Y.
    World J Pediatr; 2015 Nov; 11(4):338-45. PubMed ID: 25410673
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
    Delbet JD, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschênes G, Ulinski T.
    Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.
    Xia Y, Mao J, Chen Y, Wang D, Cao L, Yao S, Fu H, Du L, Liu A.
    Pediatr Nephrol; 2011 Jul; 26(7):1083-8. PubMed ID: 21387156
    [Abstract] [Full Text] [Related]

  • 4. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Li Y.
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between clinical manifestations and renal pathology in children with Henoch-Schonlein purpura nephritis].
    Zhang GZ, Wu XC, Yi H, Peng XJ, Dang XQ, He XJ, Yi ZW.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):129-32. PubMed ID: 17448308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Multicenter investigation of diagnosis and treatment of Henoch-Schonlein purpura nephritis in childhood].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Disease.
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):881-7. PubMed ID: 24495756
    [Abstract] [Full Text] [Related]

  • 8. Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial.
    Ding Y, Zhang X, Ren X, Zhai W, He L, Liu J, Yao C, Han S, Wang L.
    Trials; 2019 Aug 29; 20(1):538. PubMed ID: 31464626
    [Abstract] [Full Text] [Related]

  • 9. Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis.
    Yang XQ, Huang YJ, Zhai WS, Ren XQ, Guo QY, Zhang X, Yang M, Zhang J, Ding Y, Zhu S, Yamamoto T, Sun Y.
    Pediatr Nephrol; 2019 Apr 29; 34(4):663-670. PubMed ID: 30415419
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.
    Lu Z, Song J, Mao J, Xia Y, Wang C.
    Med Sci Monit; 2017 May 18; 23():2333-2339. PubMed ID: 28515415
    [Abstract] [Full Text] [Related]

  • 11. Local leukocyte proliferation as a target for cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis grade VI.
    Kaneko M, Ikezumi Y, Yamada T, Hasegawa H, Kaneko U, Saitoh A.
    Nephrology (Carlton); 2016 Jan 18; 21(1):68-71. PubMed ID: 26693846
    [Abstract] [Full Text] [Related]

  • 12. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
    Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ.
    Scand J Rheumatol; 2005 Jan 18; 34(5):392-5. PubMed ID: 16234188
    [Abstract] [Full Text] [Related]

  • 13. Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch-Schönlein purpura nephritis and persistent nephrotic syndrome.
    Ohara S, Kawasaki Y, Matsuura H, Oikawa T, Suyama K, Hosoya M.
    Clin Exp Nephrol; 2011 Oct 18; 15(5):749-753. PubMed ID: 21618075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression.
    Shenoy M, Bradbury MG, Lewis MA, Webb NJ.
    Pediatr Nephrol; 2007 Oct 18; 22(10):1717-22. PubMed ID: 17647023
    [Abstract] [Full Text] [Related]

  • 16. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
    Buscatti IM, Casella BB, Aikawa NE, Watanabe A, Farhat SCL, Campos LMA, Silva CA.
    Clin Rheumatol; 2018 May 18; 37(5):1319-1324. PubMed ID: 29330742
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of steroid and immunosuppressant combined therapy in Chinese patients with Henoch-Schönlein purpura nephritis: A retrospective study.
    Yu Y, Chen J, Yin H, Deng Z, Xie Y, Yuan Q, Xu H, Liu S, Tao L, Peng Z.
    Int Immunopharmacol; 2020 Apr 18; 81():106229. PubMed ID: 32014710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil.
    Du Y, Hou L, Zhao C, Han M, Wu Y.
    Pediatr Nephrol; 2012 May 18; 27(5):765-71. PubMed ID: 22081165
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis.
    Tan J, Tang Y, Zhong Z, Yan S, Tan L, Tarun P, Qin W.
    Int Urol Nephrol; 2019 Jun 18; 51(6):975-985. PubMed ID: 30989564
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.